Three generic blood pressure drugs — valsartan, losartan and irbesartan — as well as the heartburn drug Zantac were all recently recalled after potentially carcinogenic impurities were found in their active ingredients.
The active ingredient for the three blood pressure drugs was manufactured in China and its makerknew of the impurities, but failed to report the information, according to Politico.
The House Energy and Commerce Health Subcommittee will focus the meeting on the role of international drug companies in the U.S. drug supply chain.
More articles on pharmacy:
Novant Health leaders talk Walgreens partnership goals for 2020
Sanofi recalls heartburn drug over cancer risks
Centura Health opens retail pharmacy
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
